While COVID-19 vaccines have grabbed headlines and moved markets in recent weeks, the biotechnology sector is constantly seeing innovation that has the potential to drive returns for investors. That said, many broader healthcare indexes don't adequately capture new developments in the space. Today's note provides an overview of the S-Network Medical Breakthroughs Index (PMBI) and discusses how it's designed to provide exposure to innovation and potential M&A activity in the biotechnology sector.